Published in Cancer Weekly, July 27th, 1998
J. Sharkey et al. sought to assess the effectiveness of palladium 103 brachytherapy in Stage T1 and T2 adenocarcinoma of the prostate ("Outpatient Ultrasound-Guided Palladium 103 Brachytherapy for Localized Adenocarcinoma of the Prostate: A Preliminary Report of 434 Patients," Urology, May 1998;51(5):796-803).
"Charts of four hundred seventy four patients treated between 1991 and 1996 with transperineal real-time...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.